Restricted accessLetterFirst published online 2009-10
Early Patterns of Adherence in Adolescents Initiating Highly Active Antiretrovial Therapy Predict Long-Term Adherence,Virologic,and Immunologic Control
LimaVD, HarriganR, BangsbergDRet al.The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr, 2009; 50:529–536.
2.
BangsbergDR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis, 2006; 43:939–941.
3.
D'AngeloLJ, SamplesC, RogersAS, PeraltaL, FriedmanL. HIV infection and AIDS in adolescents: An update of the position of the Society for Adolescent Medicine. J Adolesc Heath, 2006; 38:88–91.
4.
MerzelC, VanDevanterN, IrvineM. Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts. AIDS Patient Care STDs, 2008; 22:977–987.
5.
RudyBJ, MurphyDA, HarrisDR, MuenzL, EllenJ. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: A study of prevalence and interactions. AIDS Patient Care STDs, 2009; 23:185–194.
6.
FlynnPM, RudyBJ, LindseyJCet al.Long-term observation of adolescents initiating HAART therapy: Three-year follow-up. AIDS Res Human Retroviruses, 2007; 23:1208–1214.
7.
WeiserSD, GuzmanD, RileyED, ClarkR, BangsbergDR. Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clin Trials, 2004; 5:278–287.
8.
HammerSM, EronJJ, ReissPet al.Antiretroviral treatment of adult HIV infection 2008 Recommendations of the International AIDS Society—USA Panel. JAMA, 2006; 300:555–570.
9.
HolmesWC, BilkerWB, WangH, ChapmanJ, GrossR. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr, 2007; 46:323–327.
10.
Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human ServicesJanuary 292008; 1–128. www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf Last accessed August23, 2009.
